IT1320176B1 - Dispersioni solide di principi attivi nitrati. - Google Patents

Dispersioni solide di principi attivi nitrati.

Info

Publication number
IT1320176B1
IT1320176B1 IT2000MI002803A ITMI20002803A IT1320176B1 IT 1320176 B1 IT1320176 B1 IT 1320176B1 IT 2000MI002803 A IT2000MI002803 A IT 2000MI002803A IT MI20002803 A ITMI20002803 A IT MI20002803A IT 1320176 B1 IT1320176 B1 IT 1320176B1
Authority
IT
Italy
Prior art keywords
nitrated
active ingredients
solid dispersions
dispersions
solid
Prior art date
Application number
IT2000MI002803A
Other languages
English (en)
Inventor
Laura Trespidi
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT2000MI002803A priority Critical patent/IT1320176B1/it
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to AT01995695T priority patent/ATE275393T1/de
Priority to EP04103272A priority patent/EP1496064A1/en
Priority to US10/451,016 priority patent/US20040071777A1/en
Priority to PCT/EP2001/014967 priority patent/WO2002051385A1/en
Priority to DE60105448T priority patent/DE60105448T2/de
Priority to JP2002552531A priority patent/JP2004516303A/ja
Priority to ES01995695T priority patent/ES2228983T3/es
Priority to EP01995695A priority patent/EP1347744B1/en
Publication of ITMI20002803A1 publication Critical patent/ITMI20002803A1/it
Application granted granted Critical
Publication of IT1320176B1 publication Critical patent/IT1320176B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2000MI002803A 2000-12-22 2000-12-22 Dispersioni solide di principi attivi nitrati. IT1320176B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT2000MI002803A IT1320176B1 (it) 2000-12-22 2000-12-22 Dispersioni solide di principi attivi nitrati.
EP04103272A EP1496064A1 (en) 2000-12-22 2001-12-18 Nitrate active principle
US10/451,016 US20040071777A1 (en) 2000-12-22 2001-12-18 Solid dispersions of nitrate active principles
PCT/EP2001/014967 WO2002051385A1 (en) 2000-12-22 2001-12-18 Solid dispersions of nitrate active principles
AT01995695T ATE275393T1 (de) 2000-12-22 2001-12-18 Feste dispersionen mit nitrataktiven wirkstoffen
DE60105448T DE60105448T2 (de) 2000-12-22 2001-12-18 Feste dispersionen mit nitrataktiven wirkstoffen
JP2002552531A JP2004516303A (ja) 2000-12-22 2001-12-18 ナイトレートの有効成分の固体分散体
ES01995695T ES2228983T3 (es) 2000-12-22 2001-12-18 Dispersiuones solidas de principios activos de nitrato.
EP01995695A EP1347744B1 (en) 2000-12-22 2001-12-18 Solid dispersions of nitrate active principles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI002803A IT1320176B1 (it) 2000-12-22 2000-12-22 Dispersioni solide di principi attivi nitrati.

Publications (2)

Publication Number Publication Date
ITMI20002803A1 ITMI20002803A1 (it) 2002-06-22
IT1320176B1 true IT1320176B1 (it) 2003-11-26

Family

ID=11446305

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI002803A IT1320176B1 (it) 2000-12-22 2000-12-22 Dispersioni solide di principi attivi nitrati.

Country Status (8)

Country Link
US (1) US20040071777A1 (it)
EP (2) EP1347744B1 (it)
JP (1) JP2004516303A (it)
AT (1) ATE275393T1 (it)
DE (1) DE60105448T2 (it)
ES (1) ES2228983T3 (it)
IT (1) IT1320176B1 (it)
WO (1) WO2002051385A1 (it)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
ZA200502496B (en) 2002-02-28 2005-10-12 Japan Tobacco Inc Ester compound and medicinal use thereof.
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
WO2004105728A2 (en) * 2003-05-27 2004-12-09 Ranbaxy Laboratories Limited Solid dispersions of cefpodoxime proxetil and processes for their preparation
US7790197B2 (en) 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US7655692B2 (en) 2003-06-12 2010-02-02 Pfizer Inc. Process for forming amorphous atorvastatin
EP1669345A4 (en) 2003-08-29 2008-02-20 Japan Tobacco Inc ESTER DERIVATIVE AND MEDICAL USE THEREOF
BRPI0416535A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
US20090131342A1 (en) * 2004-01-22 2009-05-21 Nitromed, Inc. Nitrosated and/or nitrosylated compounds, compositions and methods of use
US7838552B2 (en) 2004-06-04 2010-11-23 Forest Laboratories Holdings Limited Compositions comprising nebivolol
US7803838B2 (en) 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
DK1830817T3 (da) * 2004-12-30 2013-04-02 Pf Medicament Stabil, fast dispersion af et derivat af vinca-alkaloid og fremgangsmåde til fremstilling heraf
US9089544B2 (en) * 2007-08-24 2015-07-28 Slotervaart Participaties Bv Composition
EP2259777A2 (en) * 2008-02-28 2010-12-15 BIAL - Portela & Ca., S.A. Pharmaceutical composition for poorly soluble drugs
KR20100124710A (ko) * 2008-03-11 2010-11-29 닥터 레디스 레보러터리즈 리미티드 레날리도미드의 제조
KR101037808B1 (ko) * 2008-07-02 2011-05-30 한국콜마 주식회사 가용화된 니플루믹산을 함유하는 서방성 정제
RU2012121599A (ru) * 2009-10-27 2013-12-10 Люпин Лимитед Твердая дисперсия рифаксимина
JP2013521318A (ja) * 2010-03-08 2013-06-10 ラティオファルム ゲー・エム・ベー・ハー ダビガトランエテキシラートを含有する医薬組成物
SMT202000390T1 (it) 2010-07-12 2020-09-10 Salix Pharmaceuticals Inc Formulazioni di rifaximina e loro usi
CA3038312A1 (en) 2016-09-30 2018-04-05 Salix Pharmaceuticals, Inc. Solid dispersion forms of rifaximin
CN110193013B (zh) * 2019-07-02 2022-02-08 力品药业(厦门)股份有限公司 一种去乙酰真菌环氧乙酯固体分散体及其制备方法
CA3184054A1 (en) 2020-06-26 2021-12-30 Jacob Cole Targeted release rifaximin compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
IT1311922B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
WO2001015677A2 (en) * 1999-08-31 2001-03-08 Alcon Laboratories, Inc. Use of 5-ht1b/1d agonists to treat otic pain
WO2003024429A1 (en) * 2001-09-21 2003-03-27 Egalet A/S Polymer release system

Also Published As

Publication number Publication date
EP1496064A1 (en) 2005-01-12
ATE275393T1 (de) 2004-09-15
ES2228983T3 (es) 2005-04-16
EP1347744A1 (en) 2003-10-01
WO2002051385A1 (en) 2002-07-04
WO2002051385A8 (en) 2002-10-31
ITMI20002803A1 (it) 2002-06-22
US20040071777A1 (en) 2004-04-15
JP2004516303A (ja) 2004-06-03
EP1347744B1 (en) 2004-09-08
DE60105448T2 (de) 2005-09-22
DE60105448D1 (de) 2004-10-14

Similar Documents

Publication Publication Date Title
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
DE50312034D1 (de) Liposomale glucocorticoide
BRPI0407181A (pt) Formulação farmacêutica
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
EP1254899A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ES2063073T3 (es) Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios.
BR0314354A (pt) Formação para gentes lipofìlicos
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
PT1123120E (pt) Formulacao medicinal em aerossol
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
PT1112062E (pt) Composição para a administração tópica de ingredientes farmacêuticos activos
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
WO2003018619A3 (en) Antimicrobial and anti-inflammatory peptides
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
DE60130135D1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
PT989851E (pt) Formulacao auto-emulsionante para compostos lipofilicos acidicos
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
ES2152670T3 (es) Derivados de nitrito y nitrato esteroideos utiles como farmacos antiinflamatorios.
DE69818806D1 (de) Antimikrobielle kosmetische präparate
CL2011003144A1 (es) Forma cristalina e3 de bisulfato de atazanavir; composicion farmaceutica que la comprende; util para el tratamiento de enfermedades originadas por retrovirus (divisional de la solicitud 1057-05).
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.